The unique role of stigma in migraine-related disability and quality of life

被引:16
|
作者
Seng, Elizabeth K. [1 ,2 ,3 ]
Shapiro, Robert E. [4 ]
Buse, Dawn C. [1 ,2 ]
Robbins, Matthew S. [5 ]
Lipton, Richard B. [2 ,3 ]
Parker, Amanda [6 ]
机构
[1] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY 10033 USA
[2] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Montefiore Headache Ctr, 111 E 210th St, Bronx, NY 10467 USA
[4] Univ Vermont, Lerner Coll Med, Dept Neurol Sci, Burlington, VT USA
[5] Weill Cornell Med, Dept Neurol, New York, NY USA
[6] VA New York Harbor Healthcare Syst, New York, NY USA
来源
HEADACHE | 2022年 / 62卷 / 10期
关键词
ecological; migraine; quality of life; social; stigma; INFORMATION-SYSTEM PROMIS(R); AMERICAN MIGRAINE; PREVALENCE; BURDEN; RELIABILITY; DEPRESSION; VALIDATION; VALIDITY; EPILEPSY; PEOPLE;
D O I
10.1111/head.14401
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Stigma is increasingly recognized as an important social feature of living with migraine. Methods Adults with migraine recruited from neurology offices completed the validated Stigma Scale for Chronic Illnesses 8-item version (SSCI-8); two outcome measures (the Migraine Disability Assessment [MIDAS] and the Migraine-Specific Quality of Life Questionnaire v 2.1 [MSQ]); and measures of allodynia (Allodynia Symptom Checklist [ASC-12]), pain cognition (Pain Catastrophizing Scale [PCS]), and psychiatric symptoms (Patient Reported Measurement Information System Anxiety [PROMIS-A] and Depression [PROMIS-D]). Pearson and Spearman correlations evaluated bivariate relationships, and linear (MSQ) and logistic (MIDAS Severe Disability, scores >= 21) regressions evaluated the unique variance associated with SSCI-8 beyond other study variables. Conditional process analysis evaluated mediation hypotheses between study variables. Results Participants (n = 121) reported levels of stigma on par with other chronic illnesses (SSCI-8 M = 53.0, standard deviation [SD] = 7.8), with 25/127 (19.6%) reporting clinically significant levels of stigma (SSCI-8 T-score >= 60). Higher SSCI-8 scores were associated with higher monthly headache day frequency (r = 0.35), MIDAS (rho = 0.41), ASC-12 (r = 0.24, p < 0.01), PCS (r = 0.46), both PROMIS-A (r = 0.43) and D (r = 0.42), and lower MSQ subscale scores (Role Restriction r = -0.50; Role Prevention r = -0.48; Emotion Function r = -0.50), all ps <0.001 unless otherwise noted. The SSCI-8 contributed significantly beyond migraine symptoms and other psychological factors for MSQ Emotion Function (5% unique variance) and MIDAS Severe Disability (6% of unique variance). The SSCI-8 mediated relationships between headache frequency and the MSQ subscales and MIDAS Severe Disability. The PCS mediated relationships between the SSCI-8 and MSQ subscales. The PROMIS-D mediated relationships between the SSCI-8 and MSQ Role Restriction and MSQ Role Prevention. Conclusions Migraine stigma has medium to large associations with migraine outcomes and psychiatric symptoms and is independently associated with migraine disability and emotion-related quality of life. Migraine stigma is an important contributor to the relationship between headache frequency and migraine outcomes.
引用
收藏
页码:1354 / 1364
页数:11
相关论文
共 50 条
  • [1] The unique role of stigma in migraine-related disability and quality of life
    Seng, E. K.
    Shapiro, R. E.
    Buse, D. C.
    Robbins, M. S.
    Lipton, R. B.
    Parker, A.
    [J]. HEADACHE, 2022, 62 : 99 - 100
  • [2] Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life Results of the OVERCOME (US) Study
    Shapiro, Robert E.
    Nicholson, Robert A.
    Seng, Elizabeth K.
    Buse, Dawn C.
    Reed, Michael L.
    Zagar, Anthony J.
    Ashina, Sait
    Muenzel, E. Jolanda
    Hutchinson, Susan
    Pearlman, Eric M.
    Lipton, Richard B.
    [J]. NEUROLOGY, 2024, 102 (03) : e208074
  • [3] Migraine-related stigma and its influence on disability, interictal burden, and migraine specific quality of life: Results of the OVERCOME (US) study
    Shapiro, R. E.
    Nicholson, R. A.
    Seng, E. K.
    Buse, D. C.
    Reed, M. L.
    Zagar, A. J.
    Ashina, S.
    Muenzel, E. J.
    Hutchinson, S.
    Pearlman, E. M.
    Lipton, R. B.
    [J]. HEADACHE, 2022, 62 : 34 - 35
  • [4] Factors associated with migraine-related quality of life and disability in adolescents: A preliminary investigation
    Tkachuk, GA
    Cottrell, CK
    Gibson, JS
    O'Donnell, FJ
    Holroyd, KA
    [J]. HEADACHE, 2003, 43 (09): : 950 - 955
  • [5] Determinants of Migraine-Related Disability
    Lipton, Richard B.
    Blumenfeld, Andrew
    Ishak, Jack
    Varon, Sepideh F.
    Kawata, Ariane K.
    Manack, Aubrey
    Buse, Dawn C.
    Goadsby, Peter J.
    [J]. NEUROLOGY, 2010, 74 (09) : A323 - A324
  • [6] Erenumab versus topiramate: migraine-related disability, impact and health-related quality of life
    Reuter, Uwe
    Heinze, Axel
    Gendolla, Astrid
    Sieder, Christian
    Hentschke, Christian
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2024,
  • [7] Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
    Buse, Dawn C.
    Lipton, Richard B.
    Hallstrom, Yngve
    Reuter, Uwe
    Tepper, Stewart J.
    Zhang, Feng
    Sapra, Sandhya
    Picard, Hernan
    Mikol, Daniel D.
    Lenz, Robert A.
    [J]. CEPHALALGIA, 2018, 38 (10) : 1622 - 1631
  • [8] Migraine-related stigma and its association with seeking care and migraine disability: Results from OVERCOME ( EU) Study
    Novick, D.
    Zagar, A.
    Gonderten, S.
    Evers, S.
    Pascual, J.
    Dell'Agnello, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 591 - 592
  • [9] Botulinum toxin type-A, migraine and disability: A decrease in migraine-related disability
    Turner, I. M.
    Newman, S. M.
    Entin, E. J.
    Agrillo, T.
    [J]. HEADACHE, 2007, 47 (05): : 772 - 773
  • [10] Headache-Specific Locus of Control and Migraine-Related Quality of Life: Understanding the Role of Anxiety
    Amy S. Grinberg
    Elizabeth K. Seng
    [J]. International Journal of Behavioral Medicine, 2017, 24 : 136 - 143